Engage Health Inc.
7
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.3%
1 terminated/withdrawn out of 7 trials
85.7%
-0.8% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
Understanding Fabry Disease Therapy Choices Through the Eyes of the Patients
Role: collaborator
Understanding the Burden of ACC Through the Eyes of Patients
Role: collaborator
Parkinson's Disease G2019S LRRK2 Genetic Testing Program
Role: collaborator
Understanding the Spectrum of ENPP1 Deficiency and Acute ABCC6 Deficiency
Role: collaborator
Health Insurance Literacy and Challenges in Accessing Health Services in Niemann-Pick
Role: collaborator
The Burden of Access in Duchenne Muscular Dystrophy in the US
Role: collaborator
Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families
Role: collaborator
All 7 trials loaded